Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France;Émergence de la résistance aux macrolides chez Streptococcus pyogenes en pédiatrie

Pathologie Biologie

Volumn 52, Issue 8, 2004, Pages 489-492

  Mariani Kurkdjian, P ^a   Doit, C ^a   Deforche, D ^a   Brahimi, N ^a   Francois, M ^a   Van Den Abbeele, T ^a   Bingen, E ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Angine; Macrolide; Macrolides; Streptococcus pyogenes; Tonsillopharyngitis

Indexed keywords

MACROLIDE; ANTIINFECTIVE AGENT; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; CHILD; DRUG RESISTANCE; FRANCE; HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES; THROAT CULTURE; ANTIBIOTIC RESISTANCE; DRUG EFFECT; MICROBIOLOGY; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CHILD; CLARITHROMYCIN; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FRANCE; HUMANS; MACROLIDES; PENICILLINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 16544373998     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.07.032     Document Type: Article

References (40)

1. E. Bingen, N. Lambert-Zechovsky, P. Mariani-Kurkdjian, Y. Aujard, and H. Mathieu Le concept de pathognie indirecte cause dchec de certains traitements antibiotiques Sem. Hop. Paris 65 1989 1072 1078
2. C. Sauzeau, E. Bingen, N. Lambert-Zechovsky, and P. Mariani-Kurkdjian Analyse des causes dchec de lradication du Streptocoque A dans langine Le Pdiatre 106 1987 247 249
3. A. Osterlund, R. Popa, T. Nikkila, A. Scheynius, and L. Engstrand Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis Laryngoscope 107 5 1997 640 647
4. G. Falck, E. Grahn-Hakansson, S.E. Holm, K. Roos, and L. Lagergren Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study Acta Otolaryngol. 119 8 1999 944 948
5. E. Bingen, E. Denamur, N. Lambert-Zechovsky, N. Braimi, and M. El Lakany Elion J DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of Streptococcus pyogenes pharyngitis J. Med. Microbiol. 37 3 1992 162 164
6. J. Conley, M.E. Olson, L.S. Cook, H. Ceri, V. Phan, and H.D. Davies Biofilm formation by group A streptococci: is there a relationship with treatment failure? J. Clin. Microbiol. 41 2003 4043 4048
7. Antibiothrapie par voie gnrale en pratique courante: angine, AFSSAPS, Dcembre 2002 Arch. Pdiatr. 10 2003 260 271
8. E.J.L. Lowbury Symposium on epidemiological risks of antibiotics. Hospital infections Proc. R. Soc. Med. 51 1958 807 810
9. E. Sanders, M.T. Foster, and D. Scott Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin N. Engl. J. Med. 278 1968 538 540
10. F. Baquero, J.A. Garca-Rodrguez, J. Garca De Lomas, and L. Aguilar Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (19961997) multicenter surveillance study Antimicrob. Agents Chemother. 43 1999 178 180
11. A.L. Barry, P.C. Fuchs, and S.D. Brown Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA J. Antimicrob. Chemother. 40 1997 139 140
12. M. Borzani, M. De Luca, and F. Varotto A survey of susceptibility to erythromycin among Streptococcus pyogenes isolates in Italy J. Antimicrob. Chemother. 40 1997 457 458
13. A. Jasir, and C. Schaln Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes J. Antimicrob. Chemother. 41 1998 135 137
14. J. Kataja, P. Huovinen, M. Skurnik, and H. Seppala Erythromycin resistance genes in group A streptococci in Finland Antimicrob. Agents Chemother. 43 1999 48 52
15. K.P. Klugman, T. Capper, C.A. Widdowson, H.J. Koornhof, and W. Moser Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates J. Antimicrob. Chemother. 42 1998 729 734
16. R. Leclercq, and P. Courvalin Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification Antimicrob. Agents Chemother. 35 1991 1267 1272
17. H. Seppala, M. Skurnik, H. Soini, M.C. Roberts, and P. Huovinen A novel erythromycin resistance methylase gene (ermTR) Streptococcus pyogenes Antimicrob. Agents Chemother. 42 1998 257 262
18. J. Clancy, J. Petipas, F. Dib-Hajj, W. Yuan, M. Cronan, and A.V. Kamath Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes Mol. Microbiol. 22 1996 867 879
19. A. Tait-Kamradt, T. Davies, P.C. Appelbaum, F. Depardieu, P. Courvalin, and J. Petitpas Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America Antimicrob. Agents Chemother. 44 2000 3395 3401
20. Comit de l'Antibiogramme de la Socit Francaise de Microbiologie report 2003 Int J. Antimicrob. Agents 21 4 April 2003 364 391
21. NCCLS. Performance standards for antimicrobial disk susceptibility tests. 7 ed Wayne, Pa: NCCLS, 2003 Approved standard M2-A7.
22. J.C.S. de Azavedo, R.H. Yeung, and D.J. Bast Prevalence and mechanisms of macrolides resistance in clinical isolates of group A Streptococci from Ontario, Canada Antimicrob. Agents Chemother. 43 1999 2144 2147
23. D.B. Clewell, and A.E. Franke Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin B in a strain of Streptococcus pyogenes Antimicrob. Agents Chemother. 5 1974 534 537
24. J. Sutcliffe, T. Grebe, and A. Tait-Kamradt Detection of erythromycin-resistant determinants by PCR Antimicrob. Agents Chemother. 40 1996 2562 2566
25. J. Kataja, P. Huovinen, A. Muotiala, J. Vuopio-Varkila, A. Efstratiou, G. Hallas, and H. Seppl Clonal spread of group A Streptococcus with the new type of erythromycin-resistance J. Infect. Dis. 177 1998 786 789
26. E. Perez-Trallero, J.M. Marimon, J.M. Montes, B. Orden, and M. de Pablos Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain Emerg. Infect. Dis. 3 1999 235 240
27. E. Perez-Trallero, M. Urbieta, M. Montes, I. Ayestaran, and J. Marimon Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain Eur. J. Clin. Microbiol. Infect. Dis. 17 1998 25 31
28. G. Cornaglia, M. Ligozzi, A. Mazzariol, L. Masala, G. Lo Cascio, G. Orefici, and R. Fontana Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy Clin. Infect. Dis. 27 Suppl. 1 1998 S87 S92
29. E. Bingen, F. Fitoussi, C. Doit, R. Cohen, A. Tanna, and R. George Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients Antimicrob. Agents Chemother. 44 2000 1453 1457
30. C. Doit, C. Loukil, P. Geslin, and E. Bingen Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children J. Clin. Microbiol. 40 2002 2994 2998
31. B. Weisblum Erythromycin resistance by ribosome modification Antimicrob. Agents Chemother. 39 1995 577 585
32. E. Giovanetti, M.P. Montanari, and N.I. Mingoia Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducible resistant strains Antimicrob. Agents Chemother. 43 1999 1935 1940
33. I. Garcia-Bermejo, J. Cacho, B. Orden, J.I. Alos, and J.L. Gomez-Garces Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain Antimicrob. Agents Chemother. 42 1998 989 990
34. J.M. Martin, M. Green, K.A. Barbadora, and E.R. Wald Erythromycin- resistant group A streptococci in schoolchildren in Pittsburgh N. Engl. J. Med. 346 2002 1200 1206
35. K. Fujita, K. Murono, M. Yoshikawa, and T. Murai Decline of erythromycin resistance of group A streptococci in Japan Pediatr. Infect. Dis. J. 13 1994 1075 1078
36. H. Seppla, T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenus, and K. Lager The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N. Engl. J. Med. 337 1997 441 446
37. H. Seppla, T. Klaukka, R. Lehtonen, E. Nenonen, and P. Huovinen Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci Clin. Infect. Dis. 21 1995 1378 1385
38. H. Seppla, T. Klaukka, R. Lehtonen, E. Nenonen, and P. Huovinen Erythromycin resistance of group A streptococci from throat samples is related to age Pediatr. Infect. Dis. J. 16 1997 651 656
39. H. Seppala, A. Nissinen, H. Jarvinen, S. Huovinen, T. Henriksson, and E. Herva Resistance to erythromycin in group A streptococci N. Engl. J. Med. 326 1992 292 297
40. P.E. Varaldo, E.A. Debbia, G. Nicoletti, D. Pavesio, S. Ripa, and G.C. Schito Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes Clin. Infect. Dis. 29 1999 869 873